Canvuparatide (MBX 2109) is a prodrug for parathyroid hormone (PTH) peptide that releases the bioactive PTH[1-32] peptide agonist that retains a fatty acylated lysine (Lys33) at the C-terminus, thereby extending the halflife of Canvuparatide. Canvuparatide can be used for the symptoms of hypoparathyroidism such as hypocalcemia and hyperphosphatemia[1].
Molecular Weight:
5873.83
Purity:
95.48
CAS Number:
[2925554-87-4]
Formula:
C263H441N65O81S2
Target:
Thyroid Hormone Receptor
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted